Stockreport

Syros Pharma's lead candidate fails to impress in mid-stage blood cancer study; shares down 48% premarket [Seeking Alpha]

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF Syros Pharma's lead candidate fails to impress in mid-stage blood cancer study; shares down 48% premarketThinly traded micro cap Syros Pharmaceuticals (NASDAQ:SYRS) slum [Read more]